The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells

Autor: Chang, Yung-Chieh, Kondapuram, Sree Karani, Yang, Tsung-Han, Syed, Safiulla Basha, Cheng, Siao Muk, Lin, Tzu-Yu, Lin, Yi-Chen, Coumar, Mohane Selvaraj, Chang, Jang-Yang, Leung, Euphemia, Cheung, Chun Hei Antonio
Zdroj: In Toxicology and Applied Pharmacology 15 August 2020 401
Databáze: ScienceDirect